Pellets

- High potent (hormones/oncology)
- Hormonal gels
- Hormonal liquids
- Impregnated dressings
- Bottle filling for tablets

Delpharm group offers pharmaceutical services which includes capsules. It belongs to solid forms category. Capsules. Contact us for more information.

Delpharm group offers pharmaceutical services which includes sparkling. It belongs to solid forms category. Semisolids: ointment sparkling sachets. Specialties: biotechnology. Contact us for more information.

Delpharm group offers pharmaceutical services which includes coated tablets. It belongs to solid forms category. Semisolids: creamscoated tabletsdrops. Specialties: cytotoxic. Contact us for more information.

Delpharm group offers pharmaceutical services which includes sachets. It belongs to solid forms category. Sachets. Contact us for more information.

Delpharm group offers pharmaceutical services which includes film-coated tablets. It belongs to solid forms category. Semisolids: suppositories film-coated tablets bulbs. Specialties: sterile injectable. Contact us for more information.

Freeze-Drying is now available at Delpharm Saint-Rémy. 

Delpharm group offers pharmaceutical services which includes new product development. It belongs to services and commitments category. It can support your development of sourcing the active ingredients in the product registration and monitoring of the file with the health authorities in providing you with ...

Delpharm group offers pharmaceutical services which includes life cycle management. It belongs to services and commitments category. It includes extension of range, evolution due to regulatory constraints or material suppliers, optimization of mature products, etc.

- Syrups/dinkables
- Suspensions
- Drops/sprays
- Injectable ampoules final sterilization
- Injectable ampoules aseptic filling
- Vials aseptic filling
- Prefilled syringes
- Multidose eye drops

Delpharm group offers pharmaceutical services which includes life cycle management. It belongs to services and commitments category. It includes extension of range, evolution due to regulatory constraints or material suppliers, optimization of mature products, etc.

- Syrups/dinkables
- Suspensions
- Drops/sprays
- Injectable ampoules final sterilization
- Injectable ampoules aseptic filling
- Vials aseptic filling
- Prefilled syringes
- Multidose eye drops

Poznań, Poland, Thursday 15 October 2020 –GSK and Delpharm announced today they have entered into an agreement under which Delpharm will acquire GSK’s Poznań manufacturing facility in Poland.

Delpharm is a European leader in contract manufacturing and development of medicines for pharmaceutical laboratories. It owns 12 manufacturing plants (nine in France, two in Italy and one in Belgium) providing the majority of dosage forms available on the market: tablets, syrups, bottles, vials, etc. Delpharm generates €500m in turnover and is wholly-owned by its management. For more information, visit our website: http://www.delpharm.com/

Delpharm and the Famar Group are pleased to announce the acquisition by Delpharm of 5 manufacturing sites belonging to Famar, in France, Canada and the Netherlands. The transaction signed today covers the French sites located in Orléans (Loiret), L’Aigle (Orne) and Saint-Rémy-sur-Avre (Eure-et-Loire), as well as the Montreal site in Canada and that of Bladel in the Netherlands.

Delpharm is a Worldwide leader in contract manufacturing and development of medicines for pharmaceutical laboratories. It owns 17 manufacturing plants (12 in France, 2 in Italy, 1 in Belgium, 1 in the Netherlands and 1 in Canada) providing the majority of dosage forms available on the market: tablets, syrups, bottles, vials, etc. Delpharm generates €800m in turnover and is wholly-owned by its management. For more information, visit our website: http://www.delpharm.com/